Amicus Therapeutics (FOLD) Stock Chart & Stock Price History $8.00 +0.01 (+0.13%) Closing price 04:00 PM EasternExtended Trading$8.00 0.00 (-0.06%) As of 06:38 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Amicus Therapeutics Stock Price Performance 5 Day Performance-5.81%1 Month Performance-13.03%3 Month Performance-15.62%6 Month Performance-24.81%Year-To-Date Performance-15.71%1 Year Performance-30.17% Receive FOLD Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Amicus Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address FOLD Stock Chart for Thursday, April, 3, 2025 FOLD Chart by TradingViewRemove Ads Amicus Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/02/2025$7.95$7.99+0.50%$8.02$7.853.21 million shs$2.45 billion04/01/2025$8.16$7.95-2.57%$8.24$7.902.98 million shs$2.44 billion03/31/2025$8.43$8.16-3.20%$8.31$7.974.77 million shs$2.51 billion03/28/2025$8.59$8.43-1.86%$8.62$8.363.69 million shs$2.59 billion03/27/2025$8.52$8.59+0.82%$8.60$8.492.46 million shs$2.64 billion03/26/2025$8.62$8.52-1.16%$8.67$8.402.72 million shs$2.62 billion03/25/2025$8.69$8.62-0.81%$8.71$8.523.05 million shs$2.65 billion03/24/2025$9.01$8.69-3.55%$9.08$8.635.65 million shs$2.67 billion03/21/2025$9.08$9.01-0.77%$9.19$8.932.93 million shs$2.77 billion03/20/2025$9.20$9.08-1.30%$9.26$9.071.54 million shs$2.79 billion Get the Latest News and Ratings for FOLD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Amicus Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 03/19/2025$8.98$9.20+2.45%$9.23$8.981.87 million shs$2.83 billion03/18/2025$9.12$8.98-1.54%$9.17$8.971.79 million shs$2.76 billion03/17/2025$8.90$9.12+2.47%$9.12$8.852.02 million shs$2.80 billion03/14/2025$8.81$8.90+1.02%$9.00$8.791.80 million shs$2.73 billion03/13/2025$8.89$8.81-0.90%$8.94$8.731.67 million shs$2.71 billion03/12/2025$8.88$8.89+0.11%$9.00$8.802.42 million shs$2.73 billion03/11/2025$8.63$8.88+2.90%$8.96$8.573.39 million shs$2.73 billion03/10/2025$8.86$8.63-2.60%$8.91$8.552.88 million shs$2.65 billion03/07/2025$9.02$8.86-1.77%$9.04$8.802.02 million shs$2.72 billion03/06/2025$9.15$9.02-1.42%$9.21$9.001.98 million shs$2.77 billion03/05/2025$9.11$9.15+0.44%$9.18$9.062.26 million shs$2.81 billion03/04/2025$9.13$9.11-0.22%$9.20$8.992.52 million shs$2.80 billion03/03/2025$9.49$9.13-3.79%$9.47$9.122.57 million shs$2.81 billion Related Companies EXEL Stock Price Chart EXAS Stock Price Chart RGEN Stock Price Chart HALO Stock Price Chart MDGL Stock Price Chart ALKS Stock Price Chart IONS Stock Price Chart LGND Stock Price Chart DVAX Stock Price Chart BCRX Stock Price Chart Receive FOLD Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Amicus Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:FOLD) was last updated on 4/3/2025 by MarketBeat.com Staff From Our Partners“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredMost gold “analysts” aren’t really gold analysts… [watch out]People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredNew “Trump” currency proposed in DCAfter a massive run-up – tech stocks are crashing. And as you’d suspect, the rich and powerful got out firs...Paradigm Press | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amicus Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Amicus Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
